Veronika Redmann is the President of Veronika Redmann Medical Writing, LLC., which she founded in 2018. Since its founding, her company has assisted over 30 companies with their SBIR/STTR grant applications. Dr. Redmann is an entrepreneur and scientist whose passion is assisting tech companies with seeking non-dilutive funding through the SBIR/STTR grant program, with a particular expertise of creating well-written commercialization plans. Before jumping from academia to the tech start-up world, Dr. Redmann spent 10+ years at the bench designing and leading research projects in virology, immunology, molecular biology, public health, and models of human disease. Her favorite research experience was working hands-on with a live bat colony and assisting with the preparation of specimens for rabies virus testing at the Wadsworth Center’s Griffin Laboratory (Guilderland, NY). She actively serves as a grant reviewer for the National Science Foundation and partners with the Missouri SBDC to teach workshops several times a year on NSF SBIR/STTR proposal preparation. She has served as a past Entrepreneur-In-Residence at the Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship at Washington University in St. Louis. She holds a Ph.D. in Biomedical Sciences from Icahn School of Medicine at Mount Sinai, a BS in Biology and a BA in German Studies from Randolph Macon Woman’s College.
Emily Morales is a Missouri-based medical writer with experience writing research journal articles, SBIR/STTR grants, and educational materials. Prior to medical writing, Dr. Morales worked for 7+ years as a researcher at the University of Missouri, with expertise in viral gene therapy and rare genetic diseases. Her favorite part of writing SBIR/STTR grants is learning more about her Clients’ journeys. She feels inspired by their creativity and innovation. Dr. Morales holds a Ph.D. in Molecular Pathogenesis and Therapeutics from the University of Missouri and a BS in Biology from Truman State University.
Rhiannon Koehler is a veterinarian and when not in the clinic enjoys writing educational articles for the veterinary and human medical spaces. She received her Doctor of Veterinary Medicine and Master of Public Health degrees from the University of Missouri. As a clinician, she performs surgeries for animal shelters and provides wellness care for pets. Her hobbies include reading, writing, and hiking. Rhiannon enjoys working on SBIR/STTR grant projects because she feels the work of start-ups is vital to progress in the medical field. She especially enjoys projects that allow her to use her clinical knowledge. Bonus points if it has applications for both animal and human health!
Dahlia Perez is a postdoctoral fellow in the field of cardiac regeneration at the Weizmann Institute of Science. Prior to this, Dr. Perez received her doctorate in Biology from the Massachusetts Institute of Technology, specializing in cancer cell biology. She has also published in the fields of centriole duplication, cell division and heat shock proteins. A constant throughout her scientific career as she studied across varied biological disciplines has been the desire to understand basic mechanisms of biology in a translational manner. To that end, she looks forward to learning about new scientific fields and innovations, and contributing positively to the journey of start-ups through SBIR/STTR grant writing.
Stephanie Erjavec received her PhD in Genetics & Development from Columbia University for her thesis work in the functional genomics of autoimmune disease, Alopecia Areata. After her PhD, Stephanie joined IQVIA as a consultant where she conducted various Value & Access strategic projects for biopharmaceutical clients. Her projects primarily focused on commercial evaluations, disease landscape assessments,pricing strategies, competitive landscape analyses, and evidence generation strategies. At her next role at Cambrian Biopharma, Stephanie was responsible for leading the operational strategy of pipeline companies as well building out Cambrian’s Market &Commercial Insights function. She is passionate about improving patients’ access to lifesaving medicines and is thrilled to support innovative startups in winning SBIR/STTR grants to bring their medicines one step closer to patients.